AONC American Oncology Network, Inc.: Nilai pasar

Logo grafis American Oncology Network (AONC)

As illustrated on the chart, the market value of American Oncology Network (AONC) stands at 0.02, supported by a network of specialized clinics and an automated pharmacy in the US. Demand for drug procurement optimization is driving the expansion of the private medical center support niche. American Oncology Network (AONC) generates revenue by providing IT services and administrative support for physicians, helping them efficiently organize therapy for their patients.

American Oncology Network, Inc. - Biji pasar AONC (periode 21.02.2024 - 04.08.2024)

Rincian metrik lan analitis perusahaan aoncology.com (AONC)

American Oncology Network, Inc. (AONC): dhaptar indikator lan metrik:
Pambiji fundamental perusahaan:AON AONC
Sampel barang American Oncology Network, Inc.

The stability of American Oncology Network (AONC) is based on the consolidation of independent clinics into a single network. The business's market capitalization is calculated as the product of the current share price and the total number of outstanding securities. It is critical for investors to compare this total with the debt load to avoid overpaying for the asset. This metric reflects the market value of the infrastructure that supports patient access to innovative drugs. The dynamics of the business's market capitalization allow for an assessment of how partnerships with pharma behemoths impact the company's valuation.

Pesaing American Oncology Network (AONC)

Nilai pasar BeiGene ONC|Halozyme Therapeutics, Inc. (HALO) - Nilai pasar|RVMD - Nilai pasar|AAPG (Ascentage Pharma Corp) - Kapitalisasi pasar|CGON: Kapitalisasi pasar|Biji pasar urogen.com|BCAX (Bicara Therapeutics) - Kapitalisasi pasar|Biji pasar Personalis Inc (PSNL)|Kapitalisasi pasar ERAS|Kapitalisasi pasar Delcath Corp (DCTH)|Nilai pasar Y-mAbs Therapeutics YMAB|AURA: Kapitalisasi pasar|Candel - Kapitalisasi pasar|Accuray Inc (ARAY) - Biji pasar|SLS: Kapitalisasi pasar|Nilai pasar Actuate Therapeutics Inc (ACTU)|Nilai pasar Citius Oncology, Inc.|HURA: Nilai pasar|Biji pasar TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Nilai pasar|Kapitalisasi pasar WHWK (Aadi Bioscience)|TCRX - Biji pasar|CSBR: Biji pasar|XBIT - Kapitalisasi pasar|cel-sci.com (CVM) - Nilai pasar|OS Therapies Inc. - Nilai pasar|RADX (Radiopharm Theranostics) - Kapitalisasi pasar|Nilai pasar Artiva ARTV|Kapitalisasi pasar ANL|Kapitalisasi pasar verupharma.com (VERU)|Nilai pasar Tempest Therapeutics, Inc. TPST|XLO - Biji pasar|Enochian BioSciences - Kapitalisasi pasar|Nilai pasar Mural Oncology plc|kairospharma.com (KAPA) - Nilai pasar|OnKure Therapeutics - Nilai pasar|GDTC (CytoMed Therapeutics Ltd) - Kapitalisasi pasar|Curis Corp (CRIS) - Kapitalisasi pasar|Kapitalisasi pasar APLM|Biji pasar Tharimmune Corporation THAR|Kapitalisasi pasar ADVB (Advanced Biomed)|Kapitalisasi pasar genprex.com GNPX|CLDI - Nilai pasar|SBFM (sunshinebiopharma.com) - Kapitalisasi pasar|XBIO (xeneticbio.com) - Biji pasar|Salarius Pharma - Nilai pasar|Nilai pasar Purple Biotech|Nilai pasar beigene.com BGNE|Nilai pasar Checkpoint Therapeutics, Inc. (CKPT)|Elevation Oncology Inc. - Kapitalisasi pasar|Kapitalisasi pasar ICAD (iCAD)|IKNA - Biji pasar|NTBL - Nilai pasar|Nilai pasar Viracta Therapeutics|MorphoSys (MOR) - Nilai pasar|NAYA (NAYA Biosciences Inc) - Nilai pasar|Nilai pasar Ascentage Pharma Group Ltd